Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-12-27
1998-11-10
MacMillan, Keith D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514811, 514812, 514823, A61K 3114
Patent
active
058344772
ABSTRACT:
An opiate analgesic drug formulation which induces minimal respiratory dession is provided which contains a homogeneous mixture of an opiate agonist drug component and an opiate antagonist drug component in an aqueous medium, the opiate agonist component and the opiate antagonist component being present in the mixture in a molar ratio, wherein when the drug formulation is administered to a patient in an amount sufficient for the opiate agonist drug component to induce analgesia in the patient, substantially no respiratory depression is induced in the patient.
REFERENCES:
patent: 5512578 (1996-04-01), Crain et al.
Chemical Abstracts AN 1990: 191789, Moore et al, 1990.
Chemical Abstracts AN 1977: 165459, Drummond et al, 1977.
Biffoni Ulysses John
Goldberg Edward
MacMillan Keith D.
Sachs Michael C.
The United States of America as represented by the Secretary of
LandOfFree
Opiate analgesic formulation with improved safety does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Opiate analgesic formulation with improved safety, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Opiate analgesic formulation with improved safety will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1517057